Phoenix Biotech Acquisition Corp. (PBAXW) Financials

PBAXW Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2023 8.5 million 14.0 million
June 30, 2023 14.1 million 13.6 million
March 31, 2023 14.4 million 12.4 million
Dec. 31, 2022 42.4 million 39.9 million

PBAXW Free Cash Flow and Stock based compensation

No data available :(

PBAXW Net Income

No data available :(

PBAXW Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 119014 - -
June 30, 2023 105234 - -
March 31, 2023 178093 - -
Dec. 31, 2022 475870 - -

PBAXW Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 6.3 million
June 30, 2023 6.8 million
March 31, 2023 6.8 million
Dec. 31, 2022 23.0 million

PBAXW Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 - - 430901 -
June 30, 2023 - - 1.5 million -
March 31, 2023 - - 566568 -
Dec. 31, 2022 - - 1.4 million -

PBAXW Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 - -
June 30, 2023 - -
March 31, 2023 - -
Dec. 31, 2022 254831 -

PBAXW

Price: $0.06

52 week price:
0.01
0.09

Exchange: NGM

Sector: Financial Services

Industry: Shell Companies

Volume: 2400

Market Capitalization: 406527

Links: